Recent Advancement In Nanocarrier Systems For Cancer Targeting
DOI:
https://doi.org/10.22270/ajprd.v11i3.1422Abstract
Cancer is a disease that has a complicated pathological process. Current chemotherapy has issues such as lack of selectivity, cytotoxicity, generation of multi-drug resistance, and the formation of stem-like cells. The novel treatment modalities enabled by nanomaterial characteristics have expanded their reach in cancer therapy beyond traditional medication delivery. Nanotechnology has been actively researched and used in cancer treatment because nanoparticles can serve as an effective medication delivery mechanism. Nanoparticle-based drug delivery provides distinct benefits over traditional drug administration, including greater stability and biocompatibility, increased permeability and retention effect, and precision targeting. There are numerous major categories of nanomaterials utilized in cancer treatment. These nanomaterials, which target cancer cells, the tumor microenvironment, and the immune system, have been modified for a variety of cancer treatments in order to overcome toxicity and lack of selectivity, as well as to improve drug capacity and bioavailability. Furthermore, nanoparticle-based drug delivery systems have been found to help overcome cancer-related treatment resistance. In cancer therapy, nanoparticles can be used to encapsulate active pharmacological substances and deliver them to the tumor location more efficiently. This overview lists the several types of nanoparticles that have been tested in clinical trials for cancer therapy. Furthermore, the most recent advancements in the use of nanoparticles in cancer therapy are emphasized.The literature for this study was compiled using databases such as PubMed, Google Scholar, and ScienceDirect on nanoparticles in the treatment of cancer have been collected. The present article focuses on nanotechnology advancements, specifically nanocarriers for anticancer medication delivery. It covers nanoparticles, polymeric micelles, dendrimers, hydrogels system and finally the future prospects of the nanocarrier.
Downloads
References
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians. 2018 Nov;68(6):394-424.
Hanahan D. Hallmarks of cancer: new dimensions. Cancer discovery. 2022 Jan 1;12(1):31-46.
Sharma GN, Dave R, Sanadya J, Sharma P, Sharma K. Various types and management of breast cancer: an overview. Journal of advanced pharmaceutical technology & research. 2010 Apr 1;1(2):109-26.
Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. Ca Cancer J Clin. 2023 Jan 12;73(1):17-48.
Mariotto AB, Noone AM, Howlader N, Cho H, Keel GE, Garshell J, Woloshin S, Schwartz LM. Cancer survival: an overview of measures, uses, and interpretation. Journal of the National Cancer Institute Monographs. 2014 Nov 1;2014(49):145-86.
Grewal IK, Singh S, Arora S, Sharma N. Polymeric nanoparticles for breast cancer therapy: A comprehensive review. Biointerface Res. Appl. Chem. 2021;11(4):11151.
Liu L, Kshirsagar PG, Gautam SK, Gulati M, Wafa EI, Christiansen JC, White BM, Mallapragada SK, Wannemuehler MJ, Kumar S, Solheim JC. Nanocarriers for pancreatic cancer imaging, treatments, and immunotherapies. Theranostics. 2022;12(3):1030.
Talluri SV, Kuppusamy G, Karri VV, Tummala S, Madhunapantula SV. Lipid-based nanocarriers for breast cancer treatment–comprehensive review. Drug delivery. 2016 May 3;23(4):1291-305.
Manish G, Vimukta S. Targeted drug delivery system: a review. Res J Chem Sci. 2011 May;1(2):135-8.
Li DC, Zhong XK, Zeng ZP, Jiang JG, Li L, Zhao MM, Yang XQ, Chen J, Zhang BS, Zhao QZ, Xie MY. Application of targeted drug delivery system in Chinese medicine. Journal of Controlled Release. 2009 Sep 1;138(2):103-12.
Tewabe A, Abate A, Tamrie M, Seyfu A, Abdela Siraj E. Targeted drug delivery—from magic bullet to nanomedicine: principles, challenges, and future perspectives. Journal of Multidisciplinary Healthcare. 2021 Jul 5:1711-24.
Dai L, Liu J, Luo Z, Li M, Cai K. Tumor therapy: targeted drug delivery systems. Journal of materials chemistry B. 2016;4(42):6758-72.
Kumari P, Ghosh B, Biswas S. Nanocarriers for cancer-targeted drug delivery. Journal of drug targeting. 2016 Mar 15;24(3):179-91.
Ayana G, Ryu J, Choe SW. Ultrasound-responsive nanocarriers for breast cancer chemotherapy. Micromachines. 2022 Sep 11;13(9):1508.
Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nature reviews drug discovery. 2021 Feb;20(2):101-24.
Din FU, Aman W, Ullah I, Qureshi OS, Mustapha O, Shafique S, Zeb A. Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors. International journal of nanomedicine. 2017 Oct 5:7291-309.
Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. Nanocarriers as an emerging platform for cancer therapy. Nano-enabled medical applications. 2020 Nov 23:61-91.
Edis Z, Wang J, Waqas MK, Ijaz M, Ijaz M. Nanocarriers-mediated drug delivery systems for anticancer agents: an overview and perspectives. International journal of nanomedicine. 2021 Feb 17:1313-30.
Yao Y, Zhou Y, Liu L, Xu Y, Chen Q, Wang Y, Wu S, Deng Y, Zhang J, Shao A. Nanoparticle-based drug delivery in cancer therapy and its role in overcoming drug resistance. Frontiers in molecular biosciences. 2020 Aug 20;7:193.
Mundekkad D, Cho WC. Nanoparticles in clinical translation for cancer therapy. International journal of molecular sciences. 2022 Feb 1;23(3):1685.
Sharma A, Jain N, Sareen R. Nanocarriers for diagnosis and targeting of breast cancer. BioMed research international. 2013;2013(1):960821.
Hasan S. A review on nanoparticles: their synthesis and types. Res. J. Recent Sci. 2015;2277:2502.
Vauthier C, Bouchemal K. Methods for the preparation and manufacture of polymeric nanoparticles. Pharmaceutical research. 2009 May;26:1025-58.
Ficai D, Grumezescu AM, editors. Nanostructures for novel therapy: synthesis, characterization and applications. Elsevier; 2017 Feb 25.
Cheaburu-Yilmaz CN, Karasulu HY, Yilmaz O. Nanoscaled dispersed systems used in drug-delivery applications. Polymeric nanomaterials in nanotherapeutics. 2019 Jan 1:437-68.
Salatin S, Barar J, Barzegar-Jalali M, Adibkia K, Kiafar F, Jelvehgari M. Development of a nanoprecipitation method for the entrapment of a very water soluble drug into Eudragit RL nanoparticles. Research in pharmaceutical sciences. 2017 Feb 1;12(1):1-4.
Yadav KS, Sawant KK. Modified nanoprecipitation method for preparation of cytarabine-loaded PLGA nanoparticles. AapsPharmscitech. 2010 Sep;11:1456-65.
Rivas CJ, Tarhini M, Badri W, Miladi K, Greige-Gerges H, Nazari QA, Rodríguez SA, Román RÁ, Fessi H, Elaissari A. Nanoprecipitation process: From encapsulation to drug delivery. International journal of pharmaceutics. 2017 Oct 30;532(1):66-81.
Krishnamoorthy K, Mahalingam M. Selection of a suitable method for the preparation of polymeric nanoparticles: multi-criteria decision making approach. Advanced pharmaceutical bulletin. 2015 Mar;5(1):57.
Kammari R, Das NG, Das SK. Nanoparticulate systems for therapeutic and diagnostic applications. Emerging Nanotechnologies for Diagnostics, Drug Delivery and Medical Devices. 2017 Jan 1:105-44.
Ong SG, Ming LC, Lee KS, Yuen KH. Influence of the encapsulation efficiency and size of liposome on the oral bioavailability of griseofulvin-loaded liposomes. Pharmaceutics. 2016 Aug 26;8(3):25.
Bozzuto G, Molinari A. Liposomes as nanomedical devices. International journal of nanomedicine. 2015 Feb 2:975-99.
Nsairat H, Khater D, Sayed U, Odeh F, Al Bawab A, Alshaer W. Liposomes: Structure, composition, types, and clinical applications. Heliyon. 2022 May 1;8(5).
Liu P, Chen G, Zhang J. A review of liposomes as a drug delivery system: current status of approved products, regulatory environments, and future perspectives. Molecules. 2022 Feb 17;27(4):1372.
Mozafari MR. Liposomes: an overview of manufacturing techniques. Cellular and molecular biology letters. 2005 Jan 1;10(4):711.
Akbarzadeh A, Rezaei-Sadabady R, Davaran S, Joo SW, Zarghami N, Hanifehpour Y, Samiei M, Kouhi M, Nejati-Koshki K. Liposome: classification, preparation, and applications. Nanoscale research letters. 2013 Dec;8:1-9.
Laura Immordino M, Dosio F, Cattel L. Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential. International journal of nanomedicine. 2006 Sep 15;1(3):297-315.
Marianecci C, Di Marzio L, Rinaldi F, Celia C, Paolino D, Alhaique F, Esposito S, Carafa M. Niosomes from 80s to present: the state of the art. Advances in colloid and interface science. 2014 Mar 1;205:187-206.
Rajera R, Nagpal K, Singh SK, Mishra DN. Niosomes: a controlled and novel drug delivery system. Biological and Pharmaceutical Bulletin. 2011 Jul 1;34(7):945-53.
Sahin NO. Niosomes as nanocarrier systems. Nanomaterials and nanosystems for biomedical applications. 2007:67-81.
Ag Seleci D, Seleci M, Walter JG, Stahl F, Scheper T. Niosomes as nanoparticular drug carriers: fundamentals and recent applications. Journal of nanomaterials. 2016;2016(1):7372306.
Moghassemi S, Hadjizadeh A. Nano-niosomes as nanoscale drug delivery systems: an illustrated review. Journal of controlled release. 2014 Jul 10;185:22-36.
Dahiya S, Dahiya R. Potential of colloidal carriers for nanocosmeceutical applications. InNanocosmeceuticals 2022 Jan 1 (pp. 169-208). Academic Press.
Tangri P, Khurana S. Niosomes: Formulation and evaluation. International Journal. 2011;2229:7499.
Kaur D, Kumar S. Niosomes: present scenario and future aspects. Journal of drug delivery and therapeutics. 2018 Sep 6;8(5):35-43.
Newkome GR, Moorefield CN, Vögtle F, Vögtle F, Vögtle F, Chemist G. Dendrimers and dendrons: concepts, syntheses, applications. Weinheim: Wiley-vch; 2001.
Umoren SA, Solomon MM, Saji VS. Polymeric materials in corrosion inhibition: fundamentals and applications. Elsevier; 2022 Jun 1.
Wang J, Li B, Qiu L, Qiao X, Yang H. Dendrimer-based drug delivery systems: History, challenges, and latest developments. Journal of Biological Engineering. 2022 Jul 25;16(1):18.
Caminade AM, Laurent R, Majoral JP. Characterization of dendrimers. Advanced drug delivery reviews. 2005 Dec 14;57(15):2130-46.
Abbasi E, Aval SF, Akbarzadeh A, Milani M, Nasrabadi HT, Joo SW, Hanifehpour Y, Nejati-Koshki K, Pashaei-Asl R. Dendrimers: synthesis, applications, and properties. Nanoscale research letters. 2014 Dec;9:1-0.
Svenson S, Tomalia DA. Dendrimers in biomedical applications—reflections on the field. Advanced drug delivery reviews. 2012 Dec 1;64:102-15.
Chis AA, Dobrea C, Morgovan C, Arseniu AM, Rus LL, Butuca A, Juncan AM, Totan M, Vonica-Tincu AL, Cormos G, Muntean AC. Applications and limitations of dendrimers in biomedicine. Molecules. 2020 Sep 1;25(17):3982.
Boas U, Heegaard PM. Dendrimers in drug research. Chemical Society Reviews. 2004;33(1):43-63.
Helms B, Meijer EW. Dendrimers at work. Science. 2006 Aug 18;313(5789):929-30.
Cloninger MJ. Biological applications of dendrimers. Current opinion in chemical biology. 2002 Dec 1;6(6):742-8.
Aliabadi HM, Lavasanifar A. Polymeric micelles for drug delivery. Expert opinion on drug delivery. 2006 Jan 1;3(1):139-62.
Croy SR, Kwon GS. Polymeric micelles for drug delivery. Current pharmaceutical design. 2006 Dec 1;12(36):4669-84.
Mahmud A, Xiong XB, Aliabadi HM, Lavasanifar A. Polymeric micelles for drug targeting. Journal of drug targeting. 2007 Jan 1;15(9):553-84.
Deshmukh AS, Chauhan PN, Noolvi MN, Chaturvedi K, Ganguly K, Shukla SS, Nadagouda MN, Aminabhavi TM. Polymeric micelles: Basic research to clinical practice. International journal of pharmaceutics. 2017 Oct 30;532(1):249-68.
Miyata K, Christie RJ, Kataoka K. Polymeric micelles for nano-scale drug delivery. Reactive and Functional Polymers. 2011 Mar 1;71(3):227-34.
Subramani K, Ahmed W. Nanoparticulate drug delivery systems for oral cancer treatment. InEmerging Nanotechnologies in Dentistry 2012 Jan 1 (pp. 333-345). William Andrew Publishing.
Kedar U, Phutane P, Shidhaye S, Kadam V. Advances in polymeric micelles for drug delivery and tumor targeting. Nanomedicine: Nanotechnology, Biology and Medicine. 2010 Dec 1;6(6):714-29.
Gaucher G, Satturwar P, Jones MC, Furtos A, Leroux JC. Polymeric micelles for oral drug delivery. European journal of pharmaceutics and biopharmaceutics. 2010 Oct 1;76(2):147-58.
Mourya VK, Inamdar N, Nawale RB, Kulthe SS. Polymeric micelles: general considerations and their applications. Indian J Pharm Educ Res. 2011 Apr 1;45(2):128-38.
Kapare HS, Metkar SR. Micellar drug delivery system: a review. Pharmaceutical resonance. 2020;2(2):21-6.
Cabral H, Kataoka K. Progress of drug-loaded polymeric micelles into clinical studies. Journal of Controlled Release. 2014 Sep 28;190:465-76.
Ahmad Z, Shah A, Siddiq M, Kraatz HB. Polymeric micelles as drug delivery vehicles. Rsc Advances. 2014;4(33):17028-38.
Owen SC, Chan DP, Shoichet MS. Polymeric micelle stability. Nano today. 2012 Feb 1;7(1):53-65.
Ghosh B, Biswas S. Polymeric micelles in cancer therapy: State of the art. Journal of Controlled Release. 2021 Apr 10;332:127-47.
Gong J, Chen M, Zheng Y, Wang S, Wang Y. Polymeric micelles drug delivery system in oncology. Journal of Controlled Release. 2012 May 10;159(3):312-23.
Jiang J, Tong X, Zhao Y. A new design for light-breakable polymer micelles. Journal of the American Chemical Society. 2005 Jun 15;127(23):8290-1.
Samchenko Y, Ulberg Z, Korotych O. Multipurpose smart hydrogel systems. Advances in colloid and interface science. 2011 Oct 14;168(1-2):247-62.
Nikolić LB, Zdravković AS, Nikolić VD, Ilić-Stojanović SS. Synthetic hydrogels and their impact on health and environment. Cellulose-based superabsorbent hydrogels. 2019:1-29.
Madhusudanan P, Raju G, Shankarappa S. Hydrogel systems and their role in neural tissue engineering. Journal of the Royal Society Interface. 2020 Jan 29;17(162):20190505.
Wang M, Duan B. Materials and their biomedical applications. Encyclopedia of Biomedical Engineering. 2019.
Schacht EH. Polymer chemistry and hydrogel systems. InJournal of Physics: Conference Series 2004 (Vol. 3, No. 1, p. 22). IOP Publishing.
Wei W, Li H, Yin C, Tang F. Research progress in the application of in situ hydrogel system in tumor treatment. Drug Delivery. 2020 Jan 1;27(1):460-8.
Zhao YL, Stoddart JF. Azobenzene-based light-responsive hydrogel system. Langmuir. 2009 Aug 4;25(15):8442-6.
Oyen ML. Mechanical characterisation of hydrogel materials. International Materials Reviews. 2014 Jan 1;59(1):44-59.
Kharkar PM, Kiick KL, Kloxin AM. Designing degradable hydrogels for orthogonal control of cell microenvironments. Chemical Society Reviews. 2013;42(17):7335-72.
Pourshahrestani S, Zeimaran E, Kadri NA, Mutlu N, Boccaccini AR. Polymeric hydrogel systems as emerging biomaterial platforms to enable hemostasis and wound healing. Advanced healthcare materials. 2020 Oct;9(20):2000905.
Li X, Xu X, Xu M, Geng Z, Ji P, Liu Y. Hydrogel systems for targeted cancer therapy. Frontiers in Bioengineering and Biotechnology. 2023 Feb 16;11:1140436.
Zhu H, Zheng J, Oh XY, Chan CY, Low BQ, Tor JQ, Jiang W, Ye E, Loh XJ, Li Z. Nanoarchitecture-integrated hydrogel systems toward therapeutic applications. ACS nano. 2023 Apr 18;17(9):7953-78.
He ZY, Deng F, Wei XW, Ma CC, Luo M, Zhang P, Sang YX, Liang X, Liu L, Qin HX, Shen YL. Ovarian cancer treatment with a tumor-targeting and gene expression-controllable lipoplex. Scientific Reports. 2016 Mar 30;6(1):23764.
Nascimento TL, Hillaireau H, Vergnaud J, Rivano M, Deloménie C, Courilleau D, Arpicco S, Suk JS, Hanes J, Fattal E. Hyaluronic acid-conjugated lipoplexes for targeted delivery of siRNA in a murine metastatic lung cancer model. International journal of pharmaceutics. 2016 Nov 30;514(1):103-11.
Kabilova TO, Shmendel EV, Gladkikh DV, Chernolovskaya EL, Markov OV, Morozova NG, Maslov MA, Zenkova MA. Targeted delivery of nucleic acids into xenograft tumors mediated by novel folate-equipped liposomes. European Journal of Pharmaceutics and Biopharmaceutics. 2018 Feb 1;123:59-70.
Zhang L, Liu S, Liu H, Yang C, Jiang A, Wei H, Sun D, Cai Z, Zheng Y. Versatile cationic liposomes for RIP3 overexpression in colon cancer therapy and RIP3 downregulation in acute pancreatitis therapy. Journal of drug targeting. 2020 Jul 2;28(6):627-42.
Vhora I, Lalani R, Bhatt P, Patil S, Patel H, Patel V, Misra A. Colloidally stable small unilamellar stearyl amine lipoplexes for effective BMP-9 gene delivery to stem cells for osteogenic differentiation. AAPS PharmSciTech. 2018 Nov;19:3550-60.
Wei L, Guo XY, Yang T, Yu MZ, Chen DW, Wang JC. Brain tumor-targeted therapy by systemic delivery of siRNA with Transferrin receptor-mediated core-shell nanoparticles. International journal of pharmaceutics. 2016 Aug 20;510(1):394-405.
Jose A, Labala S, Venuganti VV. Co-delivery of curcumin and STAT3 siRNA using deformable cationic liposomes to treat skin cancer. Journal of drug targeting. 2017 Apr 21;25(4):330-41.
Dabbagh Moghaddam F, Akbarzadeh I, Marzbankia E, Farid M, Khaledi L, Reihani AH, Javidfar M, Mortazavi P. Delivery of melittin-loaded niosomes for breast cancer treatment: an in vitro and in vivo evaluation of anti-cancer effect. Cancer Nanotechnology. 2021 Dec;12(1):14.
El-Far SW, Abo El-Enin HA, Abdou EM, Nafea OE, Abdelmonem R. Targeting colorectal cancer cells with niosomes systems loaded with two anticancer drugs models; comparative in vitro and anticancer studies. Pharmaceuticals. 2022 Jun 30;15(7):816.
Amale FR, Ferdowsian S, Hajrasouliha S, Kazempoor R, Mirzaie A, Dakkali MS, Akbarzadeh I, Meybodi SM, Mirghafouri M. Gold nanoparticles loaded into niosomes: A novel approach for enhanced antitumor activity against human ovarian cancer. Advanced Powder Technology. 2021 Dec 1;32(12):4711-22.
You L, Liu X, Fang Z, Xu Q, Zhang Q. Synthesis of multifunctional Fe3O4@ PLGA-PEG nano-niosomes as a targeting carrier for treatment of cervical cancer. Materials Science and Engineering: C. 2019 Jan 1;94:291-302.
Akbarzadeh I, Yaraki MT, Bourbour M, Noorbazargan H, Lajevardi A, Shilsar SM, Heidari F, Mousavian SM. Optimized doxycycline-loaded niosomal formulation for treatment of infection-associated prostate cancer: An in-vitro investigation. Journal of Drug Delivery Science and Technology. 2020 Jun 1;57:101715.
Pourmoghadasiyan B, Tavakkoli F, Beram FM, Badmasti F, Mirzaie A, Kazempour R, Rahimi S, Larijani SF, Hejabi F, Sedaghatnia K. Nanosized paclitaxel-loaded niosomes: Formulation, in vitro cytotoxicity, and apoptosis gene expression in breast cancer cell lines. Molecular Biology Reports. 2022 May;49(5):3597-608.
Akbarzadeh I, Farid M, Javidfar M, Zabet N, Shokoohian B, Arki MK, Shpichka A, Noorbazargan H, Aghdaei HA, Hossein-Khannazer N, Timashev P. The optimized formulation of tamoxifen-loaded niosomes efficiently induced apoptosis and cell cycle arrest in breast cancer cells. AAPS PharmSciTech. 2022 Jan 19;23(1):57.
Ayatollahi S, Salmasi Z, Hashemi M, Askarian S, Oskuee RK, Abnous K, Ramezani M. Aptamer-targeted delivery of Bcl-xL shRNA using alkyl modified PAMAM dendrimers into lung cancer cells. The international journal of biochemistry & cell biology. 2017 Nov 1;92:210-7.
Tai Z, Ma J, Ding J, Pan H, Chai R, Zhu C, Cui Z, Chen Z, Zhu Q. Aptamer-functionalized dendrimer delivery of plasmid-encoding lncRNA MEG3 enhances gene therapy in castration-resistant prostate cancer. International journal of nanomedicine. 2020 Dec 17:10305-20.
Wang H, Zhao X, Guo C, Ren D, Zhao Y, Xiao W, Jiao W. Aptamer-dendrimer bioconjugates for targeted delivery of miR-34a expressing plasmid and antitumor effects in non-small cell lung cancer cells. PLoS One. 2015 Sep 25;10(9):e0139136.
Lee IH, An S, Yu MK, Kwon HK, Im SH, Jon S. Targeted chemoimmunotherapy using drug-loaded aptamer–dendrimer bioconjugates. Journal of controlled release. 2011 Nov 7;155(3):435-41.
Fan W, Wang X, Ding B, Cai H, Wang X, Fan Y, Li Y, Liu S, Nie S, Lu Q. Thioaptamer-conjugated CD44-targeted delivery system for the treatment of breast cancer in vitro and in vivo. Journal of Drug Targeting. 2016 Apr 20;24(4):359-71.
Barve A, Jain A, Liu H, Zhao Z, Cheng K. Enzyme-responsive polymeric micelles of cabazitaxel for prostate cancer targeted therapy. Acta biomaterialia. 2020 Sep 1;113:501-11.
Gregoriou Y, Gregoriou G, Yilmaz V, Kapnisis K, Prokopi M, Anayiotos A, Strati K, Dietis N, Constantinou AI, Andreou C. Resveratrol loaded polymeric micelles for theranostic targeting of breast cancer cells. Nanotheranostics. 2021;5(1):113.
Ameli H, Alizadeh N. Targeted delivery of capecitabine to colon cancer cells using nano polymeric micelles based on beta cyclodextrin. RSC advances. 2022;12(8):4681-91.
Wang Y, Wang X, Zhang J, Wang L, Ou C, Shu Y, Wu Q, Ma G, Gong C. Gambogic acid-encapsulated polymeric micelles improved therapeutic effects on pancreatic cancer. Chinese Chemical Letters. 2019 Apr 1;30(4):885-8.
Zhao Y, Alakhova DY, Zhao X, Band V, Batrakova EV, Kabanov AV. Eradication of cancer stem cells in triple negative breast cancer using doxorubicin/pluronic polymeric micelles. Nanomedicine: Nanotechnology, Biology and Medicine. 2020 Feb 1;24:102124.
Ding L, Li J, Wu C, Yan F, Li X, Zhang S. A self-assembled RNA-triple helix hydrogel drug delivery system targeting triple-negative breast cancer. Journal of materials chemistry B. 2020;8(16):3527-33.
Sheng Y, Gao J, Yin ZZ, Kang J, Kong Y. Dual-drug delivery system based on the hydrogels of alginate and sodium carboxymethyl cellulose for colorectal cancer treatment. Carbohydrate Polymers. 2021 Oct 1;269:118325.
Liu J, Yang TY, Dai LQ, Shi K, Hao Y, Chu BY, Hu DR, Bei ZW, Yuan LP, Pan M, Qian ZY. Intravesical chemotherapy synergize with an immune adjuvant by a thermo-sensitive hydrogel system for bladder cancer. Bioactive Materials. 2024 Jan 1;31:315-32.
Shi K, Xue B, Jia Y, Yuan L, Han R, Yang F, Peng J, Qian Z. Sustained co-delivery of gemcitabine and cis-platinum via biodegradable thermo-sensitive hydrogel for synergistic combination therapy of pancreatic cancer. Nano Research. 2019 Jun;12:1389-99.
Zheng Y, Wang W, Zhao J, Wu C, Ye C, Huang M, Wang S. Preparation of injectable temperature-sensitive chitosan-based hydrogel for combined hyperthermia and chemotherapy of colon cancer. Carbohydrate polymers. 2019 Oct 15;222:115039.
Published
How to Cite
Issue
Section
Copyright (c) 2024 Charlisar Teron, Ananta Choudhury, Nurjamal Hoque
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
.